Reducing excessive use of antipsychotic agents in nursing homes

JAMA - Journal of the American Medical Association

Volumn 318, Issue 2, 2017, Pages 118-119

  Gurwitz, Jerry H ^a,b   Bonner, Alice ^c   Berwick, Donald M ^d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Massachusetts Executive Office of Environmental Affairs   (United States)

^d INSTITUTE FOR HEALTHCARE IMPROVEMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

BEHAVIOR DISORDER; DEMENTIA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INAPPROPRIATE PRESCRIBING; MENTAL DISEASE; MORTALITY RISK; NOTE; NURSING HOME PATIENT; OFF LABEL DRUG USE; PRIORITY JOURNAL; UNITED STATES; DRUG LEGISLATION; GOVERNMENT; GOVERNMENT REGULATION; HISTORY; LEGISLATION AND JURISPRUDENCE; NURSING HOME; ORGANIZATION AND MANAGEMENT; PRESCRIPTION DRUG OVERUSE; TRENDS;

ANTIPSYCHOTIC AGENTS; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DEMENTIA; GOVERNMENT REGULATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LEGISLATION, DRUG; NURSING HOMES; PRESCRIPTION DRUG OVERUSE; UNITED STATES;

EID: 85024369754     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.7032     Document Type: Note

References (9)

1. Harris-Kojetin L, Sengupta M, Park-Lee E, et al. Long-term care providers and services users in the United States: data from the National Study of Long-Term Care Providers. Vital Health Stat 3. 2016;(38):x-xii; 1-105.
2. Centers for Medicare & Medicaid Services. National Partnership to Improve Dementia Care in Nursing Homes: antipsychotic medication use data report (March 2017). https://www.nhqualitycampaign.org/files/AP-package-20170413.pdf. Accessed June 7, 2017.
3. Centers for Medicare & Medicaid Services. National partnership to improve dementia care in nursing homes. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/National-Partnership-to-Improve-Dementia-Care-in-Nursing-Homes.html. Accessed May 11, 2017.
4. RayWA, Federspiel CF, SchaffnerW. A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse. Am J Public Health. 1980;70(5):485-491.
5. Shorr RI, Fought RL, RayWA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA. 1994;271(5):358-362.
6. Levinson DR. Medicare atypical antipsychotic drug claims for elderly nursing home residents. https://oig.hhs.gov/oei/reports/oei-07-08-00150.pdf. Accessed May 6, 2017.
7. Levinson DR. Overprescribed: the human and taxpayers' costs of antipsychotics in nursing homes. https://oig.hhs.gov/testimony/docs/2011/levinson-testimony-11302011.pdf. Accessed May 6, 2017.
8. National NursingHomeQuality Improvement Campaignwebsite. https://www.nhqualitycampaign.org. Accessed June 6, 2017.
9. Centers for Medicare & Medicaid Services. Hand in hand: a training series for nursing homes. http://www.fdhc.state.fl.us/MCHQ/Field-Ops/Training/Other-Training/CMS-Hand-in-Hand-Toolkit.pdf. Accessed June 6, 2017.